{"retracted":false,"update":{"timestamp":1470009600000,"doi":"10.1016/j.yexmp.2016.06.004","type":"err"},"doi":"10.1016/j.yexmp.2016.05.003","journal":"Experimental and Molecular Pathology","publisher":"Elsevier BV","title":"Corrigendum to “Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest” (Exp. Mol. Pathol. 2016 100(3) 506-13)"}
